These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29143702)

  • 41. An 1H-MRS framework predicts the onset of Alzheimer's disease symptoms in PSEN1 mutation carriers.
    Londono AC; Castellanos FX; Arbelaez A; Ruiz A; Aguirre-Acevedo DC; Richardson AM; Easteal S; Lidbury BA; Arcos-Burgos M; Lopera F
    Alzheimers Dement; 2014 Sep; 10(5):552-61. PubMed ID: 24239247
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Brain metabolism differs in Alzheimer's disease and Parkinson's disease dementia.
    Griffith HR; den Hollander JA; Okonkwo OC; O'Brien T; Watts RL; Marson DC
    Alzheimers Dement; 2008 Nov; 4(6):421-7. PubMed ID: 19012867
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Changes in metabolite ratios after treatment with rivastigmine in Alzheimer's disease: a nonrandomised controlled trial with magnetic resonance spectroscopy.
    Modrego PJ; Pina MA; Fayed N; Díaz M
    CNS Drugs; 2006; 20(10):867-77. PubMed ID: 16999455
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlation between neurochemical metabolism and memory function in adolescent patients with depression: A multi-voxel ¹H magnetic resonance spectroscopy study.
    Mao N; Fang J; Xie H; Liu X; Jiang X; Wang G; Cui M; Wang B; Liu Q
    Psychiatry Clin Neurosci; 2016 Apr; 70(4):167-74. PubMed ID: 26556039
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elevated brain scyllo-inositol concentrations in patients with Alzheimer's disease.
    Griffith HR; den Hollander JA; Stewart CC; Evanochko WT; Buchthal SD; Harrell LE; Zamrini EY; Brockington JC; Marson DC
    NMR Biomed; 2007 Dec; 20(8):709-16. PubMed ID: 17295394
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Frontal white matter biochemical abnormalities in first-episode, treatment-naive patients with major depressive disorder: a proton magnetic resonance spectroscopy study.
    Wang Y; Jia Y; Xu G; Ling X; Liu S; Huang L
    J Affect Disord; 2012 Feb; 136(3):620-6. PubMed ID: 22129769
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of Anterior Cingulate Cortex (ACC) and Left Cerebellar Metabolism in Asperger's Syndrome with Proton Magnetic Resonance Spectroscopy (MRS).
    Goji A; Ito H; Mori K; Harada M; Hisaoka S; Toda Y; Mori T; Abe Y; Miyazaki M; Kagami S
    PLoS One; 2017; 12(1):e0169288. PubMed ID: 28060873
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Age-related differences in metabolites in the posterior cingulate cortex and hippocampus of normal ageing brain: a 1H-MRS study.
    Reyngoudt H; Claeys T; Vlerick L; Verleden S; Acou M; Deblaere K; De Deene Y; Audenaert K; Goethals I; Achten E
    Eur J Radiol; 2012 Mar; 81(3):e223-31. PubMed ID: 21345628
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study.
    Waldman AD; Rai GS
    Neuroradiology; 2003 Aug; 45(8):507-12. PubMed ID: 12879326
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Positron emission tomography metabolic correlates of apathy in Alzheimer disease.
    Marshall GA; Monserratt L; Harwood D; Mandelkern M; Cummings JL; Sultzer DL
    Arch Neurol; 2007 Jul; 64(7):1015-20. PubMed ID: 17620493
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Higher glutamate+glutamine and reduction of N-acetylaspartate in posterior cingulate according to age range in patients with cognitive impairment and/or pain.
    Fayed N; Andrés E; Viguera L; Modrego PJ; Garcia-Campayo J
    Acad Radiol; 2014 Sep; 21(9):1211-7. PubMed ID: 24981958
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Different apathy clinical profile and neural correlates in behavioral variant frontotemporal dementia and Alzheimer's disease.
    Fernández-Matarrubia M; Matías-Guiu JA; Cabrera-Martín MN; Moreno-Ramos T; Valles-Salgado M; Carreras JL; Matías-Guiu J
    Int J Geriatr Psychiatry; 2018 Jan; 33(1):141-150. PubMed ID: 28240379
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Magnetic resonance spectroscopic study of Alzheimer's disease and frontotemporal dementia/Pick complex.
    Mihara M; Hattori N; Abe K; Sakoda S; Sawada T
    Neuroreport; 2006 Mar; 17(4):413-6. PubMed ID: 16514368
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multimodal imaging in diagnosis of Alzheimer's disease and amnestic mild cognitive impairment: value of magnetic resonance spectroscopy, perfusion, and diffusion tensor imaging of the posterior cingulate region.
    Zimny A; Szewczyk P; Trypka E; Wojtynska R; Noga L; Leszek J; Sasiadek M
    J Alzheimers Dis; 2011; 27(3):591-601. PubMed ID: 21841260
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Associations Between Recent Heavy Drinking and Dorsal Anterior Cingulate N-Acetylaspartate and Glutamate Concentrations in Non-Treatment-Seeking Individuals with Alcohol Dependence.
    Prisciandaro JJ; Schacht JP; Prescot AP; Renshaw PF; Brown TR; Anton RF
    Alcohol Clin Exp Res; 2016 Mar; 40(3):491-6. PubMed ID: 26853538
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD.
    Jessen F; Block W; Träber F; Keller E; Flacke S; Papassotiropoulos A; Lamerichs R; Heun R; Schild HH
    Neurology; 2000 Sep; 55(5):684-8. PubMed ID: 10980734
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study.
    Huang W; Alexander GE; Chang L; Shetty HU; Krasuski JS; Rapoport SI; Schapiro MB
    Neurology; 2001 Aug; 57(4):626-32. PubMed ID: 11524470
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia.
    Jessen F; Scherk H; Träber F; Theyson S; Berning J; Tepest R; Falkai P; Schild HH; Maier W; Wagner M; Block W
    Schizophr Res; 2006 Oct; 87(1-3):81-8. PubMed ID: 16842971
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study.
    Nordahl TE; Salo R; Natsuaki Y; Galloway GP; Waters C; Moore CD; Kile S; Buonocore MH
    Arch Gen Psychiatry; 2005 Apr; 62(4):444-52. PubMed ID: 15809412
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Common 1H-MRS Characteristics in Patients With Alzheimer's Disease and Vascular Dementia Diagnosed With Kidney Essence Deficiency Syndrome: A Preliminary Study.
    Guo Z; Liu X; Cao Y; Hou H; Chen X; Chen Y; Huang F; Chen W
    Altern Ther Health Med; 2017 May; 23(3):12-18. PubMed ID: 28236618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.